FDA OKs test that IDs hepatitis C virus genotypes

06/21/2013 | HealthDay News · GenomeWeb Daily News (free registration)

The FDA has approved the Abbott RealTime HCV Genotype II test, which can help doctors guide treatment by differentiating genotypes 1, 1a, 1b, 2, 3, 4 and 5 of the hepatitis C virus. The new test is intended for use in patients known to have the infection and not as a diagnostic test or a screening tool for blood, according to the FDA.

View Full Article in:

HealthDay News · GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT